Right Atrial Volume Index in Chronic Systolic Heart Failure and Prognosis
John A. Sallach, MD*,
W.H. Wilson Tang, MD ,
Allen G. Borowski, RDCS ,
Wilson Tong, MS ,
Tama Porter, MD ,
Maureen G. Martin, RDCS ,
Susan E. Jasper, RN ,
Kevin Shrestha, AB ,
Richard W. Troughton, MB, ChB ,
Allan L. Klein, MD ,*
* University of Michigan, Ann Arbor, Michigan
Cleveland Clinic, Cleveland, Ohio
Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
* Reprint requests and correspondence: Dr. Allan L. Klein, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J1-5, Cleveland, Ohio 44195 (Email: kleina{at}ccf.org).
Objectives: The aim of this study was to determine the relationship between right atrial volume index (RAVI) and right ventricular (RV) systolic and diastolic function, as well as long-term prognosis in patients with chronic systolic heart failure (HF).
Background: RV dysfunction is associated with poor prognosis in patients with HF, although echocardiographic assessment of RV systolic and diastolic dysfunction is challenging. The ability to visualize the RA allows a quantitative, highly reproducible assessment of the RA volume that can be indexed to body surface area.
Methods: The ADEPT (Assessment of Doppler Echocardiography for Prognosis and Therapy) trial enrolled 192 subjects with chronic systolic HF (left ventricular ejection fraction [LVEF] 35%). The RA volume was calculated by Simpson's method using single-plane RA area and indexed to body surface area (RAVI). RV systolic function was graded as normal, mild, mild-moderate, moderate, moderately severe, or severe dysfunction.
Results: In our study cohort, the mean RAVI was 28 ± 15 ml/m2, and increased with worsening RV systolic dysfunction, LVEF, and LV diastolic dysfunction (Spearman's r = 0.61, r = 0.26, and r = 0.51, respectively; p < 0.001 for all). RAVI correlated modestly with echocardiographic estimates of RV diastolic dysfunction, including tricuspid early/late velocities ratio (Spearman's r = 0.34, p < 0.0001), hepatic vein systolic/diastolic ratio (Spearman's r = –0.26, p < 0.001) but not tricuspid early/tricuspid annular early velocities ratio (E/Ea) (Spearman's r = 0.12, p = 0.11). Increasing tertiles of RAVI were predictive of death, transplant, and/or HF hospitalization (log-rank p = 0.0002) and remained an independent predictor of adverse clinical events after adjusting for age, B-type natriuretic peptide, LV ejection fraction, RV systolic dysfunction, and tricuspid E/Ea ratio (hazard ratio: 2.00, 95% confidence interval: 1.15 to 3.58, p = 0.013).
Conclusions: In patients with chronic systolic HF, RAVI is a determinant of right-sided systolic dysfunction. This quantitative and reproducible echocardiographic marker provides independent risk prediction of long-term adverse clinical events.
Key Words: right atrial volume right ventricular systolic function echocardiography Doppler
|
Abbreviations and Acronyms
| | BNP = B-type natriuretic peptide | | E/A ratio = tricuspid early/late velocities ratio | | E/Ea ratio = tricuspid early/tricuspid annular early velocities ratio | | HF = heart failure | | HR = hazard ratio | | LV = left ventricular | | LVEF = left ventricular ejection fraction | | RA = right atrium | | RAVI = right atrial volume index | | ROC = receiver-operator characteristic | | RV = right ventricle/ventricular | | S/D = hepatic vein systolic/diastolic ratio | | TDI = tissue Doppler imaging |
|
|